CHRONIC HEPATITIS C

This study tested whether adding an investigational drug called MP-424 to the standard two-drug treatment was safe and effective for people with a specific type of hepatitis C (genotype 2) whose infection had returned after previous therapy. It involved 108 participants and measu…

This study tested whether higher daily doses of the medication ursodeoxycholic acid (UDCA) were better than a low dose at reducing liver inflammation in people with chronic hepatitis C. Nearly 600 participants in Japan took different doses of the drug for 24 weeks. The main goal …

This study tested whether adding an experimental drug called MP-424 to two standard hepatitis C medications could help patients whose infection returned after previous treatment. The trial involved 109 people with a specific type of hepatitis C who had relapsed. Researchers measu…

This study tested whether adding a new drug called MP-424 to two standard hepatitis C medications could help patients who didn't respond to prior treatment. It involved 10 people with a specific type of hepatitis C (genotype 2) that had resisted earlier therapy. The goal was to s…

This was a very early study to check the safety and basic behavior of a new drug called MP-424 in people with a specific type of chronic Hepatitis C. It involved just 10 patients who had never taken certain other Hepatitis C medications. Researchers gave a single dose and then ca…